Targeting high circulating dipeptidyl peptidase 3 in
circulatory failure
Critical Care volume 29,
Article number: 340, Published: 31 July 2025
Abstract
Circulating dipeptidyl peptidase 3 is a new biomarker linked
to circulatory failure prognosis and pathophysiology and is a potential
actionable therapeutic target. In this short review intended for the clinician,
a question-and-answer format provides key insights on the nature of this
biomarker and the therapeutical potential of its targeted inhibition in
critically ill patients.
No comments:
Post a Comment